New York Life Investment Management’s Federated Hermes FHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$361K 1028
2024
Q1
$361K Buy
10,000
+1,329
+15% +$46.7K ﹤0.01% 1188
2023
Q4
$294K Sell
8,671
-199
-2% -$6.48K ﹤0.01% 1226
2023
Q3
$300K Sell
8,870
-1,407
-14% -$48.5K ﹤0.01% 1154
2023
Q2
$368K Sell
10,277
-1,486
-13% -$57.4K ﹤0.01% 1113
2023
Q1
$472K Sell
11,763
-4,892
-29% -$192K 0.01% 1052
2022
Q4
$605K Buy
16,655
+1,787
+12% +$62.7K 0.01% 765
2022
Q3
$492K Buy
14,868
+1,176
+9% +$40.1K 0.01% 757
2022
Q2
$435K Buy
+13,692
New +$434K 0.01% 840

Other funds holding FHI

New York Life Investment Management's FHI Position: Q2 2024 in Review

New York Life Investment Management sold out of Federated Hermes (FHI) in Q2 2024, closing a stake of 10,000 shares — an estimated $361K sold.

New York Life Investment Management first reported a position in FHI in Q2 2022 and held it in 8 quarters. The position peaked at $605K in Q4 2022. 310 funds tracked by Wall St. Rank hold FHI as of Q2 2024.

  • New York Life Investment Management reported no remaining Federated Hermes position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 10,000 Federated Hermes shares in Q2 2024, an estimated $361K.
  • New York Life Investment Management first reported a position in Federated Hermes in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Federated Hermes position peaked at $605K in Q4 2022.
  • 310 funds tracked by Wall St. Rank held Federated Hermes as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.